Latest update July 2022



Hanka van de Merwe

Growing nr of active users on the Trial Eye platform

Ability and efficiency to find and refer patients effectively to any open clinical oncology trial.

Clinical trial specifics in the Netherlands and Belgium

Facts and figures

Heyleys 1 year in Belgium

More than 20.000 visitors.

If you want to receive all our News updates directly into your mailbox....

Press release Philine van den Tol appointed as CEO ad interim at iClusion

Janssen Roepman Oncologie UpToDate sept2018

You might also like these articles

Latest update July 2022

July 4, 2022


Read all about the latest highlights and planned activities here.

Philine van den Tol | CEO ad interim

May 30, 2022


Philine van den Tol appointed as CEO ad interim

iClusion presenting Heyleys on Dutch oncology days 2022

May 20, 2022


Visit us | Heyleys Stand nr. 19 at the Dutch Oncology days in Ede location Reehorst.